| Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) S Angers, A Salahpour, E Joly, S Hilairet, D Chelsky, M Dennis, M Bouvier Proceedings of the National Academy of Sciences 97 (7), 3684-3689, 2000 | 1039 | 2000 |
| DIMERIZATION: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function S Angers, A Salahpour, M Bouvier Annual review of pharmacology and toxicology 42 (1), 409-435, 2002 | 742 | 2002 |
| Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants JP Morello, A Salahpour, A Laperrière, V Bernier, MF Arthus, M Lonergan, ... The Journal of clinical investigation 105 (7), 887-895, 2000 | 650 | 2000 |
| Quantitative assessment of β1-and β2-adrenergic receptor homo-and heterodimerization by bioluminescence resonance energy transfer JF Mercier, A Salahpour, S Angers, A Breit, M Bouvier Journal of Biological Chemistry 277 (47), 44925-44931, 2002 | 598 | 2002 |
| Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting A Salahpour, S Angers, JF Mercier, M Lagacé, S Marullo, M Bouvier Journal of Biological Chemistry 279 (32), 33390-33397, 2004 | 379 | 2004 |
| Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics B Masri, A Salahpour, M Didriksen, V Ghisi, JM Beaulieu, RR Gainetdinov, ... Proceedings of the National Academy of Sciences 105 (36), 13656-13661, 2008 | 365 | 2008 |
| Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo JM Beaulieu, E Tirotta, TD Sotnikova, B Masri, A Salahpour, ... Journal of Neuroscience 27 (4), 881-885, 2007 | 313 | 2007 |
| β1/β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy C Lavoie, JF Mercier, A Salahpour, D Umapathy, A Breit, LR Villeneuve, ... Journal of Biological Chemistry 277 (38), 35402-35410, 2002 | 300 | 2002 |
| Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus V Bernier, JP Morello, A Zarruk, N Debrand, A Salahpour, M Lonergan, ... Journal of the American Society of Nephrology 17 (1), 232-243, 2006 | 264 | 2006 |
| Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter A Salahpour, AJ Ramsey, IO Medvedev, B Kile, TD Sotnikova, ... Proceedings of the National Academy of Sciences 105 (11), 4405-4410, 2008 | 198 | 2008 |
| Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo KM Lohr, AI Bernstein, KA Stout, AR Dunn, CR Lazo, SP Alter, M Wang, ... Proceedings of the National Academy of Sciences 111 (27), 9977-9982, 2014 | 193 | 2014 |
| Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor S Espinoza, A Salahpour, B Masri, TD Sotnikova, M Messa, LS Barak, ... Molecular pharmacology 80 (3), 416-425, 2011 | 184 | 2011 |
| Functional significance of oligomerization of G-protein-coupled receptors A Salahpour, S Angers, M Bouvier Trends in Endocrinology & Metabolism 11 (5), 163-168, 2000 | 184 | 2000 |
| Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor LS Barak, A Salahpour, X Zhang, B Masri, TD Sotnikova, AJ Ramsey, ... Molecular pharmacology 74 (3), 585-594, 2008 | 163 | 2008 |
| Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits ST Masoud, LM Vecchio, Y Bergeron, MM Hossain, LT Nguyen, ... Neurobiology of disease 74, 66-75, 2015 | 154 | 2015 |
| Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2 AR Meloni, GB Fralish, P Kelly, A Salahpour, JK Chen, RJ Wechsler-Reya, ... Molecular and cellular biology 26 (20), 7550-7560, 2006 | 152 | 2006 |
| BRET biosensors to study GPCR biology, pharmacology, and signal transduction A Salahpour, S Espinoza, B Masri, V Lam, LS Barak, RR Gainetdinov Frontiers in endocrinology 3, 105, 2012 | 136 | 2012 |
| Association of calnexin with wild type and mutant AVPR2 that cause nephrogenic diabetes insipidus JP Morello, A Salahpour, UE Petäjä-Repo, A Laperrière, M Lonergan, ... Biochemistry 40 (23), 6766-6775, 2001 | 135 | 2001 |
| Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease KM Lohr, ST Masoud, A Salahpour, GW Miller European Journal of Neuroscience 45 (1), 20-33, 2017 | 120 | 2017 |
| The dopamine metabolite 3-methoxytyramine is a neuromodulator TD Sotnikova, JM Beaulieu, S Espinoza, B Masri, X Zhang, A Salahpour, ... PloS one 5 (10), e13452, 2010 | 109 | 2010 |
